Uniqure NV
Ownership
Ownership Structure
Who owns Uniqure NV (QURE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 83.1% of the shares are freely tradable; institutional investors hold 84.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| venBio Select Advisor LLC | 9.61 | 6,727,777 | +12.9 | 06/30/2026 |
| JPMorgan Chase & Co | 6.95 | 4,867,755 | +71.6 | 06/30/2026 |
| RTW INVESTMENTS, LLC | 5.63 | 3,941,572 | +52.4 | 06/30/2026 |
| State Street Corp | 4.15 | 2,903,825 | +28.5 | 06/30/2026 |
| Aberdeen Group PLC | 4.07 | 2,848,117 | -46.3 | 06/30/2026 |
| BlackRock Inc | 2.68 | 1,877,453 | +8.3 | 06/30/2026 |
| Orbimed Advisors LLC | 2.58 | 1,807,486 | -15.4 | 06/30/2026 |
| Jane Street Group LLC | 2.30 | 1,610,483 | +153.2 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 3.11 | 2,179,626 | +2.7 | 10/30/2026 |
| JPMorgan Growth Advantage A | 2.44 | 1,707,744 | -2.2 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Abi-Saab Walid | Chief Medical Officer | 166,985 | 4,107,831 $ | Oct 30, 2026 | direct |
| Meek David D. | Director | 30,667 | 754,408 $ | Nov 6, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | Meek David D. | Director | Sell | 9,080 | 21.25 | 192,950 |
| Oct 30, 2026 | Abi-Saab Walid | Chief Medical Officer | Other | 18,750 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.